Organs-on-chips: Progress, challenges, and future directions

The National Institutes of Health Microphysiological Systems (MPS) program, led by the National Center for Advancing Translational Sciences, is part of a joint effort on MPS development with the Defense Advanced Research Projects Agency and with regulatory guidance from FDA, is now in its final year of funding. The program has produced many tangible outcomes in tissue chip development in terms of stem cell differentiation, microfluidic engineering, platform development, and single and multi-organ systems—and continues to help facilitate the acceptance and use of tissue chips by the wider community. As the first iteration of the program draws to a close, this Commentary will highlight some of the goals met, and lay out some of the challenges uncovered that will remain to be addressed as the field progresses. The future of the program will also be outlined. Impact statement This work is important to the field as it outlines the progress and challenges faced by the NIH Microphysiological Systems program to date, and the future of the program. This is useful information for the field to be aware of, both for current program stakeholders and future awardees and partners.

[1]  Josue A. Goss,et al.  Microfluidic heart on a chip for higher throughput pharmacological studies. , 2013, Lab on a chip.

[2]  J. Kim,et al.  Human fallopian tube epithelium co-culture with murine ovarian follicles reveals crosstalk in the reproductive cycle. , 2016, Molecular human reproduction.

[3]  A K Capulli,et al.  Approaching the in vitro clinical trial: engineering organs on chips. , 2014, Lab on a chip.

[4]  W M Reichert,et al.  Human Vascular Microphysiological System for in vitro Drug Screening , 2016, Scientific Reports.

[5]  J. Arrowsmith.  Trial watch: Phase III and submission failures: 2007–2010 , 2011, Nature Reviews Drug Discovery.

[6]  Qing Yang,et al.  Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor. , 2015, Biomicrofluidics.

[7]  Danny D Shen,et al.  Development of a microphysiological model of human kidney proximal tubule function. , 2016, Kidney international.

[8]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[9]  L M Sweeney,et al.  A cell culture analogue of rodent physiology: Application to naphthalene toxicology. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  S. George,et al.  Design considerations to minimize the impact of drug absorption in polymer-based organ-on-a-chip platforms. , 2017, Lab on a chip.

[11]  Albert Gough,et al.  A human liver microphysiology platform for investigating physiology, drug safety, and disease models , 2016, Experimental biology and medicine.

[12]  Alan Wells,et al.  All-human microphysical model of metastasis therapy , 2013, Stem Cell Research & Therapy.

[13]  Yordan Kostov,et al.  The Design and Fabrication of Three‐Chamber Microscale Cell Culture Analog Devices with Integrated Dissolved Oxygen Sensors , 2008, Biotechnology progress.

[14]  Luke P. Lee,et al.  Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications , 2015, Scientific Reports.

[15]  George Church,et al.  Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy , 2015, Science.

[16]  Stephanie J Hachey,et al.  3D microtumors in vitro supported by perfused vascular networks , 2016, Scientific Reports.

[17]  Shuichi Takayama,et al.  Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems , 2007, Proceedings of the National Academy of Sciences.

[18]  Jong Hwan Sung,et al.  A combined pharmacokinetic-pharmacodynamic (PK-PD) model for tumor growth in the rat with UFT administration. , 2009, Journal of pharmaceutical sciences.

[19]  Orlando S. Hoilett,et al.  Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit , 2016, Journal of Neuroinflammation.

[20]  Daniel C Leslie,et al.  A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice , 2012, Science Translational Medicine.

[21]  J. Kim,et al.  Microphysiological modeling of the reproductive tract: A fertile endeavor , 2014, Experimental biology and medicine.

[22]  K. Parker,et al.  Acute pergolide exposure stiffens engineered valve interstitial cell tissues and reduces contractility in vitro. , 2016, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[23]  J. Arrowsmith.  Trial watch: Phase II failures: 2008–2010 , 2011, Nature Reviews Drug Discovery.

[24]  Alan Wells,et al.  A microphysiological system model of therapy for liver micrometastases , 2014, Experimental biology and medicine.

[25]  Danilo A. Tagle,et al.  Facilitating the commercialization and use of organ platforms generated by the microphysiological systems (Tissue Chip) program through public–private partnerships , 2016, Computational and structural biotechnology journal.

[26]  Linda G. Griffith,et al.  Human Vascular Tissue Models Formed from Human Induced Pluripotent Stem Cell Derived Endothelial Cells , 2014, Stem Cell Reviews and Reports.

[27]  J. Kim,et al.  Recreating the female reproductive tract in vitro using iPSC technology in a linked microfluidics environment , 2013, Stem Cell Research & Therapy.

[28]  George A. Truskey,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014, Nature Medicine.

[29]  M. Pangalos,et al.  Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework , 2014, Nature Reviews Drug Discovery.

[30]  Gordana Vunjak-Novakovic,et al.  HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease , 2013, Stem Cell Research & Therapy.

[31]  C. David Page,et al.  Human pluripotent stem cell-derived neural constructs for predicting neural toxicity , 2015, Proceedings of the National Academy of Sciences.

[32]  A. Lee,et al.  A microfluidic platform for generating large-scale nearly identical human microphysiological system arrays , 2014 .

[33]  Kristin M. Fabre,et al.  Organs-on-chips (microphysiological systems): tools to expedite efficacy and toxicity testing in human tissue , 2014, Experimental biology and medicine.

[34]  D. Ingber,et al.  Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.

[35]  Uwe Marx,et al.  Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing. , 2016, ALTEX.

[36]  Yu-Hsiang Hsu,et al.  A microfluidic platform for generating large-scale nearly identical human microphysiological vascularized tissue arrays. , 2013, Lab on a chip.